EVENT INTELLIGENCE PLATFORM

AI Drug Discovery & Development Summit USA 2025 Attendee List

Leverage the sample of the enriched attendee list for AI Drug Discovery & Development Summit USA 2025 to spot professionals in leadership roles, explore sponsor details, connect with companies attending, and get access to verified emails. This data is sourced via Vendelux, blending organizer disclosures and intelligent forecasting.

Maximize Your Impact At AI Drug Discovery & Development Summit USA 2025

AI Drug Discovery & Development Summit USA 2025, taking place on November 18 in Boston, Massachusetts, brings together senior executives, scientists, and business leaders shaping the future of pharmaceutical innovation through artificial intelligence. This event focuses on actionable strategies for applying AI to speed up target identification, optimize lead discovery, and enhance clinical outcomes. Attendees have deep involvement in budgets related to R&D tools, data platforms, and vendor selection for machine learning infrastructure within life sciences enterprises.

Decision-makers at this summit are typically heads of R&D, CTOs, innovation officers, and directors of drug discovery from pharmaceutical and biotechnology companies, as well as AI startups and research institutions. Many are seeking new strategic partnerships, evaluating platforms that support predictive modeling, and allocating funds for collaborative pilot programs. With Vendelux’s enriched attendee list, you can filter by company focus or department, helping your team prioritize outreach to senior stakeholders who are ready to engage before the event begins.

How Sales, Marketing and Revops Teams Can Use This Attendee List

The enriched conference attendee list from Vendelux allows sales and marketing teams to effectively segment contacts based on function, from bioinformatics directors to technology heads leading AI adoption within R&D. You can use the attendee data to identify which pharma companies are evaluating vendors for machine learning tools, allowing you to match messaging with their innovation pipelines.

Early outreach lets your team schedule meetings directly with those managing AI pilot budgets. By understanding attendees’ technical priorities in advance, your reps can approach conversations with clear use cases and projected impact. After the event, follow up with detailed proposals that reflect discussions or session themes your prospects participated in. The enriched list helps you reach people who influence multi-year investments in drug discovery platforms.

Timing Is Everything

AI Drug Discovery & Development Summit USA 2025 is scheduled for November 18, 2025. Engaging with conference attendees several months ahead of the event is crucial, especially given that Q4 is a critical time for pharma teams to assess vendors and outline next year’s development priorities. By using the Vendelux attendee list now, your team can align account-based campaigns with those likely to be evaluating technology investments during the summit.

Pre-event communication can secure time with R&D leaders before their schedules fill. Post-event follow-through becomes more productive when informed by who they met, what panels they attended, and what partnerships matter most to them in 2026.

What’s Included In The AI Drug Discovery & Development Summit USA 2025 Attendee List?

Vendelux provides visibility into the executive-level attendees expected at AI Drug Discovery & Development Summit USA 2025 using a mix of organizer data and predictive modeling based on past behavior, job titles, and company involvement. You can upload your list of strategic accounts to reveal which of your targets are predicted to attend.

The enriched attendee list includes first and last names, job titles, company names, company websites, locations including city, state, and country, LinkedIn profiles, verified email addresses, and phone numbers when available.

Where Is AI Drug Discovery & Development Summit USA 2025?

The event will take place in Boston, Massachusetts, United States. Final venue details are to be announced.

When Is AI Drug Discovery & Development Summit USA 2025?

The summit is scheduled for November 18, 2025.

What Type Of Event Is AI Drug Discovery & Development Summit USA 2025?

This is a one-day industry summit focused on the application of artificial intelligence across the pharmaceutical development cycle. The event includes panel discussions, case study presentations, and structured networking for professionals in biotech, pharma, machine learning, and computational chemistry.

How Many People Attend AI Drug Discovery & Development Summit USA 2025?

The event is expected to draw approximately 250 senior-level attendees representing pharmaceutical companies, biotech firms, AI vendors, and academic research institutions. Most participants hold director-level or higher titles across AI innovation, drug discovery, data science, and research and development. Guests primarily come from North America, Europe, and Asia.

Unless expressly stated, Vendelux is not endorsed by, affiliated with, authorized by, or in any way officially connected to any event organizer or any of its subsidiaries or affiliates. All product and company names are the registered trademarks of their original owners. The use of any trade name or trademark not owned by Vendelux is for identification and reference purposes only and does not imply any association with such trademark holder.
 
If you are the organizer of this event and wish to provide the complete attendee list for this event to help ensure the accuracy of our data, please contact our Organizer Partnerships team. Submission of attendee information is voluntary and subject to verification. By providing this data, you represent that you have the legal right to share such information and that doing so does not violate any applicable laws, privacy policies, or contractual obligations.
 

Vendelux effortlessly booked over 20 meetings with our core ICP stakeholders across two events - more than triple what we were able to do on our own.

Aaron Bollinger

Chief Revenue Officer (CRO), Voltage

Get the Data